No Data
Baolingbao Biology (002286.SZ): Songjing Investment has cumulatively increased its shareholding by 0.325%.
On January 7, Gelonghui reported that Baolingbao Biology (002286.SZ) announced that as of the date of this announcement, the implementation period of the current Shareholding plan has passed the halfway mark. Songjing Investment has cumulatively increased its holdings of the company's Stocks by 1,201,600 shares, accounting for 0.3250% of the company's total share capital. This Shareholding plan has not yet been completed, and Songjing Investment will continue to increase its holdings of the company's shares in accordance with the relevant Shareholding plan within the implementation period. As of the date of this announcement, Songjing Investment holds 18,581,737 shares of the company, accounting for 5.0253% of the company's total share capital.
Baolingbao Biology Investing Up to 622 Million Yuan in US Project
baolingbao (002286.SZ) third quarter equity distribution: 0.35 yuan per 10 shares.
Baolingbao Biology (002286.SZ) released an announcement, the company's dividend distribution plan for the third quarter of 2024 is: based on the company...
Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues
Baolingbao (002286.SZ): Products such as red clover alcohol and maltodextrin with pharmaceutical excipient qualifications have been expanded for use in the pharmaceutical field.
Gelonghui November 4th | baolingbao (002286.SZ) stated on the investor interaction platform that, at present, the company has expanded the application of erythritol and maltodextrin with pharmaceutical excipients qualifications in the pharmaceutical field.
Bowling Bao: Report for the third quarter of 2024
Pinning Down Baolingbao Biology Co.,Ltd.'s (SZSE:002286) P/E Is Difficult Right Now
